Christophe E. Redon

National Cancer Institute

Full Professor(heuristic)

Lung Cancer Research Studies · Oncology

h-index52

i10-index96

Publications387

Citations15,675

Grants

No NSF/NIH grants on record.

Career Trajectory

Research Cluster Map

Direct collaborators. Node size = influence, colour = community, dashed = past collaboration.

Potential Collaborators

Recent Publications

Last 2 years · showing 20 of 115

Polycomb-mediated 3D-genome organization controls replication timing
Science Advances · 2026-06-26 · 1 citations
Replication origin flexibility: a tool to mitigate the hazards of excess replication
Trends in Genetics · 2026-03-19
Figure S1 from Extrachromosomal DNA Amplification Contributes to Small Cell Lung Cancer Heterogeneity and Is Associated with Worse Outcomes
2025-12-11
Figure S3 from Extrachromosomal DNA Amplification Contributes to Small Cell Lung Cancer Heterogeneity and Is Associated with Worse Outcomes
2025-12-11
Table S2 from Extrachromosomal DNA Amplification Contributes to Small Cell Lung Cancer Heterogeneity and Is Associated with Worse Outcomes
2025-12-11
Figure 1 extended data from Extrachromosomal DNA Amplification Contributes to Small Cell Lung Cancer Heterogeneity and Is Associated with Worse Outcomes
2025-12-11
Figure S5 from Extrachromosomal DNA Amplification Contributes to Small Cell Lung Cancer Heterogeneity and Is Associated with Worse Outcomes
2025-12-11
Figure S2 from Extrachromosomal DNA Amplification Contributes to Small Cell Lung Cancer Heterogeneity and Is Associated with Worse Outcomes
2025-12-11
Figure S4 from Extrachromosomal DNA Amplification Contributes to Small Cell Lung Cancer Heterogeneity and Is Associated with Worse Outcomes
2025-12-11
Table S8 from Extrachromosomal DNA Amplification Contributes to Small Cell Lung Cancer Heterogeneity and Is Associated with Worse Outcomes
2025-12-11
Table S7 from Extrachromosomal DNA Amplification Contributes to Small Cell Lung Cancer Heterogeneity and Is Associated with Worse Outcomes
2025-12-11
Table S4 from Extrachromosomal DNA Amplification Contributes to Small Cell Lung Cancer Heterogeneity and Is Associated with Worse Outcomes
2025-12-11
Table S6 from Extrachromosomal DNA Amplification Contributes to Small Cell Lung Cancer Heterogeneity and Is Associated with Worse Outcomes
2025-12-11
Table S5 from Extrachromosomal DNA Amplification Contributes to Small Cell Lung Cancer Heterogeneity and Is Associated with Worse Outcomes
2025-12-11
Table S1 from Extrachromosomal DNA Amplification Contributes to Small Cell Lung Cancer Heterogeneity and Is Associated with Worse Outcomes
2025-12-11
Figure 2 extended data from Extrachromosomal DNA Amplification Contributes to Small Cell Lung Cancer Heterogeneity and Is Associated with Worse Outcomes
2025-12-11
Table S3 from Extrachromosomal DNA Amplification Contributes to Small Cell Lung Cancer Heterogeneity and Is Associated with Worse Outcomes
2025-12-11
Supplementary Figure S4 from Schlafen 11 (SLFN11) Kills Cancer Cells Undergoing Unscheduled Re-replicationPreprint
2025-11-27
Supplementary Table S2 from Schlafen 11 (SLFN11) Kills Cancer Cells Undergoing Unscheduled Re-replication
2025-11-27
Supplementary Figure S2 from Schlafen 11 (SLFN11) Kills Cancer Cells Undergoing Unscheduled Re-replicationPreprint
2025-11-27

Open author page on OpenAlex →